ArticleBMC cardiovascular disorders2025
Interpretable artificial intelligence model for predicting heart failure severity after acute myocardial infarction.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review and meta - analysis of risk prediction models for heart failure after PCI in patients with acute myocardial infarction.BMC cardiovascular disorders · 2026Pooled it
- Development and validation of a multimodal machine learning prediction model for heart failure after acute myocardial infarction.Clinical and experimental medicine · 2026Article
- Investigating the utilization of LIME-enhanced AI and generated data for evaluating the risks associated with radial artery puncture procedures.Scientific reports · 2026Article
- Clinical and Inflammatory Determinants of Heart Failure Severity Following Myocardial Infarction: Implications for Post-Infarction Care.Journal of cardiovascular development and disease · 2026Article
- Development and Validation of an Explainable Machine Learning Model for Predicting Repeat Catheter Ablation for Atrial Fibrillation: A Single-Center Retrospective Cohort Study.International journal of general medicine · 2026Article
- Artificial intelligence in early heart failure detection: from algorithms to bedside integration.Frontiers in cardiovascular medicine · 2026Article
- Nonlinear association between visceral fat metabolism score and heart failure: insights from LightGBM modeling and SHAP-Driven feature interpretation in NHANES.BMC medical informatics and decision making · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHeart failure (HF) after acute myocardial infarction (AMI) is a leading cause of mortality and morbidity worldwide. Accurate prediction and early identification of HF severity are crucial for initiating preventive measures and optimizing treatment strategies. This study aimed to develop an interpretable artificial intelligence (AI) model for HF severity prediction using multidimensional clinical data.
methodsThis study included data from 1574 AMI patients, including medical history, clinical features, physiological parameters, laboratory test, coronary angiography and echocardiography results. Both deep learning (TabNet, Multi-Layer Perceptron) and machine learning (Random Forest, XGboost) models were employed in constructing model. Additionally, the Shapley Additive Explanation (SHAP) method was used to elucidate clinical factors importance and enhance model interpretability. A web platform ( https://prediction-killip-gby.streamlit.app/ ) was also developed to facilitate clinical application.
resultsAmong the models, TabNet demonstrated the best performance, achieving an AUROC of 0.827 for KILLIP four-class classification and 0.831 for KILLIP binary classification. Key clinical factors such as GRACE score, NT-pro BNP, and TIMI score were highly correlated with KILLIP classification, aligning with established clinical knowledge.
conclusionsBy leveraging easily accessible multidimensional data, this model enables accurate early prediction and personalized diagnosis of HF risk and severity following AMI. It supports early clinical intervention and improves patient outcomes, offering significant clinical application value. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.